Recent advances in biocompatible surface-modifying additives for cardiopulmonary bypass

Perfusion

Volumn 18, Issue SUPPL. 1, 2003, Pages 41-45

  Vijay, Venkataramana ^a   McKusker, Kevin ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOPOLYMER; PLASMA PROTEIN; POLY(2 ETHYLHEXYLACRYLATE); POLY(2 HYDROXYETHYLACRYLATE); POLY(2 METHOXYETHYLACRYLATE); POLY(2 PHENOXYETHYLACRYLATE); POLY(ETHYL ACRYLATE); POLYMACON; POLYMETHACRYLIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; BIOCOMPATIBILITY; BIOFILTRATION; BIOTECHNOLOGY; CARDIOPULMONARY BYPASS; CHEMICAL STRUCTURE; COMPLEMENT SYSTEM; EQUIPMENT DESIGN; PRIORITY JOURNAL; SURFACE PROPERTY; SURGICAL TECHNIQUE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; THROMBOCYTE ADHESION;

ACRYLATES; ACRYLIC RESINS; ADSORPTION; BIOCOMPATIBLE MATERIALS; BIOPOLYMERS; BIOSENSING TECHNIQUES; BLOOD PLATELETS; BLOOD PROTEINS; CARDIOPULMONARY BYPASS; CELL ADHESION; COATED MATERIALS, BIOCOMPATIBLE; FIBRINOGEN; HUMANS; MOLECULAR STRUCTURE; POLYHYDROXYETHYL METHACRYLATE; POLYMERS; SERUM ALBUMIN; SURFACE PROPERTIES; TIME FACTORS;

EID: 0037278614     PISSN: 02676591     EISSN: None     Source Type: Journal    
DOI: 10.1191/0267659103pf626oa     Document Type: Article

References (20)

1. Gu YJ, Boonstra PW, Rijnsburger AA et al. Cardiopulmonary bypass circuit treated with surface-modifying additives: a clinical evaluation of blood compatibility. Ann Thorac Surg 1998; 65: 1342-47.
2. Defraigne JO, Pincemail J, Dekoster G et al. SMA circuits reduce platelet consumption and platelet factor release during cardiac surgery. Ann Thorac Surg 2000; 70: 2075-81.
3. Rubens FD, Labow RS, Lavallee GR et al. Hematologic evaluation of cardiopulmonary bypass circuits prepared with a novel block co-polymer. Ann Thorac Surg 1999; 67: 689-98.
4. Eberhart RC, Li J, Sly MK et al. Scintigraphic analysis of cell adhesion in oxygenators and internal organs. The 23rd Annual Meeting, Society for Biomaterials, New Orleans, LA, USA 1997.
5. Tanaka M, Motomura T, Kawada M et al. Blood compatible aspects of poly(2-methoxyethylacrylate) (PMEA) - relationship between protein adsorption and platelet adhesion on PMEA surface. Biomaterials 2000; 21: 1471-81.
6. Saito N, Motoyama S, Sawamoto J. Effect of new polymer-coated extracorporeal circuits on biocompatibility during cardiopulmonary bypass. Artificial Organs 2000; 24: 547-54.
7. Schiel L, Burns S, Nogawa A et al. X coating: a new biopassive polymer coating. Can Perfusion 2001; 11: 8-17.
8. Moen O, Hogasen K, Fosse E et al. Attenuation of changes in leukocyte surface markers and complement activation with heparin-coated cardiopulmonary bypass. Ann Thorac Surg 1997; 63: 105-11.
9. Hsu LC. Heparin-coated cardiopulmonary bypass circuits: current status. Perfusion 2001; 16: 417-28.
10. Gunaydin S. Clinical performance and hemobiocompatibility of new polymer (poly2-methoxyethylacrylate) coated extracorporeal circuit - a comparative study. Ann Thorac Surg in press.
11. Gourlay T. Biomaterial development for cardiopulmonary bypass. Perfusion 2001; 16: 381-90.
12. Horisberger J, Jegger D, Boone Y et al. Impact of a remote pump head on neonatal priming volumes. Perfusion 1999; 14: 351-56.
13. De Somer F, Foubert L, Poelaert, Dujardin D, Van Nooten G, Francois K. Low extracorporeal priming volumes for infants: a benefit? Perfusion 1996; 11: 445-60.
14. McCusker K, Vijay V, DeBois W et al. MAST system: a new condensed cardiopulmonary bypass circuit for adult cardiac surgery. Perfusion 2001; 16: 447-52.
15. McCusker K, Vijay V, Helm V et al. Clinical outcomes of complete X-coating circuit in MAST condensed bypass setting. J Extra Corporeal Technol 2002; 34: 78-81.
16. Harig F, Hohenstein B, von der Emde J et al. Modulating IL-6 and IL-10 levels of pharmacologic strategies and the impact of different extracorporeal circulation parameters during cardiac surgery. Shock 2001; 16(Suppl 1): 33-38.
17. Harig F, Feyrer R, Mahmoud FO et al. Reducing the post-pump syndrome by using heparin-coated circuit, steroids, or aprotinin. Thorac Cardiovasc Surg 1999; 47: 111-18.
18. Gott JP, Cooper WA, Schmidt FE Jr et al. Modifying risk for extracorporeal circulation: trial of four anti-inflammatory strategies. Ann Thorac Surg 1998; 66: 747-53.
19. Larsson R, Elgue G, Larsson A et al. Inhibition of complement activation by soluble recombinant CR1 under conditions resembling those in a cardiopulmonary circuit: reduced up-regulation of CD11b and complete abrogation of binding of PMNs to the biomaterial surface. Immunopharmacology 1997; 38: 119-27.
20. De Somer F, Van Belleghem Y, Caes F et al. Phosphorylcholine coating offers natural platelet preservation during cardiopulmonary bypass. Perfusion 2002; 17: 39-44.